atamestane has been researched along with estrone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, J; Blom, JH; Ennemoser, O; Habenicht, UF; Horniger, W; Schröder, FH; Schulze, H; Schweikert, HU; Senge, T; Tunn, UW | 1 |
| Bono, AV; Eickenberg, HU; Fletcher, MS; Fourcade, RO; Radlmaier, A; Reis Santos, JM; van Aubel, OG | 1 |
1 trial(s) available for atamestane and estrone
| Article | Year |
|---|---|
Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study Group.
Topics: Aged; Androgens; Androstenedione; Aromatase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrone; Humans; Male; Middle Aged; Placebos; Prostatic Hyperplasia | 1996 |
1 other study(ies) available for atamestane and estrone
| Article | Year |
|---|---|
Effects of estrogen deprivation on human benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Androstenedione; Aromatase Inhibitors; Estradiol; Estrone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia | 1993 |